Pharmaceuticals

Organizations

• Novartis AGSwitzerland. 3 claims, 2 cases.
• Purdue Pharma L.P.United States. 4 claims, 3 cases.

Claims

• Supported4
• Contradicted1
• Outdated1
• Unresolved1

• Supported83
  Purdue said in November 2025 that the bankruptcy court would confirm its new plan, which provides about US$7.4 billion in cash to creditors.
  Purdue Pharma L.P.Company statement, 14 November 20254 records citedCorporate status
• Outdated94
  Purdue said in May 2023 that the Second Circuit had upheld its plan of reorganization, which included releases of opioid claims against members of the Sackler family.
  Purdue Pharma L.P.Company statement, 30 May 20232 records citedCorporate status
• Supported87
  The US Justice Department said Purdue Pharma pleaded guilty in November 2020 to three federal felonies tied to its opioid marketing.
  Purdue Pharma L.P.Regulator statement, 24 November 20202 records citedFraud
• Supported87
  The US Justice Department said in June 2020 that Novartis Hellas conspired to bribe employees of state-owned and state-controlled hospitals and clinics in Greece.
  Novartis AGRegulator statement, 25 June 20203 records citedBribery
• Supported83
  Novartis said in June 2020 that its US resolutions contained no allegations of bribery of Greek politicians, in line with its own internal investigation.
  Novartis AGCompany statement, 25 June 20202 records citedBribery
• Unresolved59
  Witness testimony placed before the Greek parliament in 2018 alleged that Novartis bribed ten Greek politicians, including two former prime ministers.
  Novartis AGPress report, 22 February 20188 records citedBribery
• Contradicted88
  Purdue's original OxyContin label said that delayed absorption from OxyContin tablets was believed to reduce the drug's abuse liability.
  Purdue Pharma L.P.Official report, 31 July 20074 records citedProduct claims